Search for: "Green v. Pfizer Inc"
Results 21 - 40
of 53
Sort by Relevance
|
Sort by Date
30 Apr 2011, 5:22 am
Pfizer, Inc. v. [read post]
29 Apr 2011, 1:03 pm
Pfizer, Inc. v. [read post]
29 Apr 2011, 7:43 am
Pfizer Inc. [read post]
21 Apr 2011, 1:36 pm
Id. at *1-2That’s one.Next, in Green v. [read post]
15 Apr 2011, 6:02 am
Rhoads & Sons, Inc. v. [read post]
18 Mar 2011, 10:04 am
Pfizer, 196 F. [read post]
9 Mar 2010, 12:20 am
Though the justices almost never reveal their reasons for recusal, this one is almost certainly based on Roberts' stock ownership in Pfizer, which also became an issue in last year's landmark pre-emption case Wyeth v. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
7 Jan 2010, 1:32 pm
The dicta in Green v. [read post]
7 Jan 2010, 10:54 am
The opinion turns on the trial court’s subsequent decertification of both the UCL and breach of warranty claims based on issues relating to absent class member reliance set forth in the Second District’s decision in Pfizer, Inc. v. [read post]
7 Jan 2010, 10:36 am
Aug. 23, 2007); Greene v. [read post]
12 Nov 2009, 9:17 am
Green v. [read post]
16 Aug 2009, 9:51 pm
In reliance of Black & Decker, Inc. v Robert Bosch Tool Corp (2008) Microsoft argued that the objective prong of the willfulness analysis is satisfied only if a defendant fails to present valid defences during the proceedings. [read post]
15 Apr 2009, 4:44 am
Friends for All Children, Inc. v. [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
2 Oct 2008, 6:00 am
Rost from Pfizer. [read post]
18 Sep 2008, 8:56 pm
Conference of September 29, 2008 __________________ Docket: 07-811 Case name: Morris, et al. v Center for Bio-Ethical Reform, Inc. et al. [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt) Germany Federal Patent Court publishes guidelines on colour trade mark Signal Yellow:… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
